Epidemiology of acromegaly: review of population studies
- PMID: 27743174
- PMCID: PMC5334410
- DOI: 10.1007/s11102-016-0754-x
Epidemiology of acromegaly: review of population studies
Abstract
Acromegaly is a rare condition necessitating large population studies for the generation of reliable epidemiological data. In this review, we systematically analysed the epidemiological profile of this condition based on recently published population studies from various geographical areas. The total prevalence ranges between 2.8 and 13.7 cases per 100,000 people and the annual incidence rates range between 0.2 and 1.1 cases/100,000 people. The median age at diagnosis is in the fifth decade of life with a median diagnostic delay of 4.5-5 years. Acral enlargement and coarse facial features are the most commonly described clinical manifestations. At the time of detection, most of the tumors are macroadenomas possibly relating to diagnostic delays and posing challenges in the surgical management. Increased awareness of acromegaly amongst the medical community is of major importance aiming to reduce the adverse sequelae of late diagnosis and treatment, improve patient outcomes and, hopefully, reduce the burden on the health care system.
Keywords: Acromegaly; Epidemiology; Incidence; Prevalence.
Similar articles
-
Incidence and prevalence of acromegaly in a large US health plan database.Pituitary. 2016 Jun;19(3):262-7. doi: 10.1007/s11102-015-0701-2. Pituitary. 2016. PMID: 26792654 Free PMC article.
-
[Epidemiology of acromegaly in Spain].Endocrinol Nutr. 2013 Oct;60(8):470-4. doi: 10.1016/j.endonu.2012.09.010. Epub 2012 Dec 13. Endocrinol Nutr. 2013. PMID: 23246411 Review. Spanish.
-
Symptoms and signs of acromegaly: an ongoing need to raise awareness among healthcare practitioners.J Prim Health Care. 2016 Jun;8(2):157-63. doi: 10.1071/HC15033. J Prim Health Care. 2016. PMID: 27477558
-
Epidemiology of acromegaly in Italy: analysis from a large longitudinal primary care database.Endocrine. 2018 Sep;61(3):533-541. doi: 10.1007/s12020-018-1630-4. Epub 2018 May 24. Endocrine. 2018. PMID: 29797214
-
The changing landscape of acromegaly - an epidemiological perspective.Rev Endocr Metab Disord. 2024 Aug;25(4):691-705. doi: 10.1007/s11154-024-09875-z. Epub 2024 Feb 10. Rev Endocr Metab Disord. 2024. PMID: 38337125 Review.
Cited by
-
Evaluation of sex hormone profile and semen parameters in acromegalic male patients.J Endocrinol Invest. 2021 Dec;44(12):2799-2808. doi: 10.1007/s40618-021-01593-6. Epub 2021 May 28. J Endocrinol Invest. 2021. PMID: 34050506
-
Predicting Subtype of Growth Hormone Pituitary Adenoma based on Magnetic Resonance Imaging Characteristics.J Comput Assist Tomogr. 2022 Jan-Feb 01;46(1):124-130. doi: 10.1097/RCT.0000000000001249. J Comput Assist Tomogr. 2022. PMID: 35099144 Free PMC article.
-
Clinical and functional outcome of total hip arthroplasty in patients with acromegaly: mean twelve year follow-up.Int Orthop. 2022 Aug;46(8):1741-1747. doi: 10.1007/s00264-022-05447-5. Epub 2022 May 21. Int Orthop. 2022. PMID: 35597862
-
Clinical characteristics and treatment outcomes in acromegaly, a retrospective single-center case series from Thailand.Pan Afr Med J. 2021 Sep 10;40:31. doi: 10.11604/pamj.2021.40.31.29920. eCollection 2021. Pan Afr Med J. 2021. PMID: 34795812 Free PMC article.
-
Physical exercise improves functional capacity and quality of life in patients with acromegaly: a 12-week follow-up study.Endocrine. 2019 Nov;66(2):301-309. doi: 10.1007/s12020-019-02011-x. Epub 2019 Jul 17. Endocrine. 2019. PMID: 31317523
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources